An observational study in Triage Risk Stratification, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-25.
Sponsored by University Hospital, Basel, Switzerland · Observational
This study is to develop a tool capable of improved risk prediction regarding the 30-day mortality. Based on vital signs, impaired mobility on presentation (IMOP), Clinical Frailty Scale (CFS) and patients' symptomatology three risk categories (low, intermediate, high risk) will be established.
Most Emergency Departments (EDs) perform an initial risk stratification of patients, called Triage. Establishing a diagnosis is key for the administration of the appropriate treatment and the following disposition decision. The earlier and the more accurate the final diagnosis is established, the shorter the time to treatment and time to disposition, and thus, the more efficient the patient flow. New ways to improve diagnosis accuracy early on in patients' ED visits are needed. Although a great number of well validated and widely used triage systems exists, to this date no gold standard in triage risk stratification has been established. Most of the existing triage systems rely on the measurement of vital signs and a list of chief complaints.
This study is to develop a tool capable of improved risk prediction regarding the 30-day mortality. Based on vital signs, impaired mobility on presentation (IMOP), Clinical Frailty Scale (CFS) and patients' symptomatology three risk categories (low, intermediate, high risk) will be established.
According to acuity patients undergo triage or directly proceed to the treatment unit. Patients awaiting triage will be approached by a member of the study personnel and will be verbally informed about the study. Afterwards, patients will be interviewed asking about their symptoms and their reason for presentation. Patients in need of immediate therapy will receive therapy before start of the interview. Following the interview, patients undergo routine triage.The physician performing initial triage will be asked to rate how ill patients appear to be using a numeric scale ranging from 0 (perfect condition) to 10 (extremely ill). Treating physician's will be asked to state their suspected diagnosis as well as differential diagnoses. Follow-up to assess 30-day and 1-year mortality rate and date of death will start one year after the end of the inclusion period.
University Hospital, Basel, Switzerland is the lead sponsor of 989 studies on the registry; 189 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients presenting to the ED of the University Hospital Basel over a time-course of 9 weeks from 25.03.2019 to 27.05.2019.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
all patients admitted to the emergency ward and awaiting triage are observed
Other: Assessment of symptoms patients presenting when admitted to ED · Other: Reason for patient presentation at ED · Other: physicians rating of severity of illness · Diagnostic Test: Assessment of vital signs · Other: Clinical Frailty Scale · Other: Impaired mobility on presentation (IMOP) · Other: Assessment of suspected diagnosis and differential diagnoses
Questionnaire with a predefined list of 35 symptoms
Exploratory interview assessing reason for patient presentation at ED
numeric scale ranging from 0 (perfect condition) to 10 (extremely ill)
Assessment of vital signs (heart rate, blood pressure, body temperature, respiration rate, peripheral capillary haemoglobin oxygen saturation)
Assessment of frailty by Clinical Frailty Scale (CFS): assess patients' frailty level from 1, very fit, to 9, terminally ill
Assessment of IMOP: defined as being unable to stand unaided or walk without help
Assessment of treating physician's suspected diagnosis and differential diagnoses. Answers will be recorded in free text form.
30-day mortality
30-day mortality is defined as death within 30 days of the day of presentation to the ED
Time frame: within 30 days of the day of presentation to the ED
Number of hospitalizations
Hospitalization is defined as the direct admission from the ED to any hospital in-patient department with a stay of over 24 hours
Time frame: day of presentation to the ED
Number of ICU-admissions
ICU-admission is defined as any direct admission to the ICU of the University Hospital of Basel
Time frame: day of presentation to the ED
Death rate (In-hospital mortality)
In-hospital mortality is defined as death occurring during presentation to the ED and hospital discharge
Time frame: from day of presentation to the ED to day of hospital discharge (assessed within 365 days of the day of presentation to the ED)
Number of institutionalisations
Institutionalisation is defined as no time spent at home during 365 days following presentation
Time frame: within 365 days of the day of presentation to the ED
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Basel, Switzerland →